{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:53:34Z","timestamp":1788800014547,"version":"build-2803163510"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Erythropoietic-stimulating agents such as erythropoietin have been used as part of patient blood management programs to reduce or even avoid the use of allogeneic blood transfusions. We review the literature to evaluate the effect of preoperative erythropoietin use on the risk of exposure to perioperative allogeneic blood transfusions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>The study involved a systematic review and meta-analysis of randomized controlled trials evaluating the use of preoperative erythropoietin. The primary outcome was the reported incidence of allogeneic red blood cell transfusions during inpatient hospitalizations. Secondary outcomes included phase-specific allogeneic red blood cell transfusions (ie, intraoperative, postoperative), intraoperative estimated blood loss, perioperative hemoglobin levels, length of stay, and thromboembolic events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 32 randomized controlled trials (n = 4750 patients) were included, comparing preoperative erythropoietin (n = 2482 patients) to placebo (n = 2268 patients). Preoperative erythropoietin is associated with a significant decrease in incidence of allogeneic blood transfusions among all patients (n = 28 studies; risk ratio, 0.59; 95% CI, 0.47\u20130.73;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) as well as patients undergoing cardiac (n = 9 studies; risk ratio, 0.55; 95% CI, 0.37\u20130.81;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .003) and elective orthopedic (n = 5 studies; risk ratio, 0.36; 95% CI, 0.28\u20130.46;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001) surgery compared to placebo, respectively. Preoperative erythropoietin was also associated with fewer phase-specific red blood cell transfusions. There was no difference between groups in incidence of thromboembolic events (n = 28 studies; risk ratio, 1.02; 95% CI, 0.78\u20131.33;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .68).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Preoperative erythropoietin is associated with a significant reduction in perioperative allogeneic blood transfusions. This finding is also confirmed among the subset of patients undergoing cardiac and orthopedic surgery. Furthermore, our study demonstrates no significant increase in risk of thromboembolic complications with preoperative erythropoietin administration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000004005","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T22:24:43Z","timestamp":1547591083000},"page":"981-992","source":"Crossref","is-referenced-by-count":85,"title":["Impact of Preoperative Erythropoietin on Allogeneic Blood Transfusions in Surgical Patients: Results From a Systematic Review and Meta-analysis"],"prefix":"10.1213","volume":"128","author":[{"given":"Brian C.","family":"Cho","sequence":"first","affiliation":[{"name":"Department of Anesthesiology\/Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Serini","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology\/Critical Care Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Zorrilla-Vaca","sequence":"additional","affiliation":[{"name":"Universidad del Valle School of Medicine, Cali, Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Virginia Commonwealth University School of Medicine, Richmond, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Gehrie","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve M.","family":"Frank","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology\/Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Grant","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology\/Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2014.2726","article-title":"Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis.","volume":"311","author":"Rohde","year":"2014","journal-title":"JAMA"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jamasurg.2018.1565","article-title":"Association of perioperative red blood cell transfusions with venous thromboembolism in a North American registry.","volume":"153","author":"Goel","year":"2018","journal-title":"JAMA Surg"},{"key":"R3-20230721","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/ALN.0000000000000945","article-title":"Morbidity and mortality after high-dose transfusion.","volume":"124","author":"Johnson","year":"2016","journal-title":"Anesthesiology"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/tme.12475","article-title":"Blood conservation in cardiac surgery.","volume":"28","author":"Blaudszun","year":"2018","journal-title":"Transfus Med"},{"key":"R5-20230721","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/ALN.0000000000001851","article-title":"Implementing a health system-wide patient blood management program with a clinical community approach.","volume":"127","author":"Frank","year":"2017","journal-title":"Anesthesiology"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1540-8191.2006.00241.x","article-title":"Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis.","volume":"21","author":"Alghamdi","year":"2006","journal-title":"J Card Surg"},{"key":"R7-20230721","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-3148.1998.00171.x","article-title":"Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators.","volume":"8","author":"Laupacis","year":"1998","journal-title":"Transfus Med"},{"key":"R8-20230721","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.arth.2013.01.024","article-title":"The use of preoperative erythropoiesis-stimulating agents (ESAs) in patients who underwent knee or hip arthroplasty: a meta-analysis of randomized clinical trials.","volume":"28","author":"Alsaleh","year":"2013","journal-title":"J Arthroplasty"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1600-6143.2012.04019.x","article-title":"Randomized trial of short-course high-dose erythropoietin in donation after cardiac death kidney transplant recipients.","volume":"12","author":"Aydin","year":"2012","journal-title":"Am J Transplant"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0140-6736(93)91143-A","article-title":"Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement.","volume":"341","year":"1993","journal-title":"Lancet"},{"key":"R12-20230721","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1245\/ASO.2005.06.031","article-title":"Preoperative epoetin alfa in colorectal surgery: a randomized, controlled study.","volume":"12","author":"Christodoulakis","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S0003-4975(97)00839-4","article-title":"Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients.","volume":"64","author":"D\u2019Ambra","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/ALN.0000000000000321","article-title":"Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial).","volume":"121","author":"Dardashti","year":"2014","journal-title":"Anesthesiology"},{"key":"R15-20230721","first-page":"533","article-title":"Baseline hemoglobin as a predictor of risk of transfusion and response to epoetin alfa in orthopedic surgery patients.","volume":"25","author":"deAndrade","year":"1996","journal-title":"Am J Orthop"},{"key":"R16-20230721","first-page":"235","article-title":"Recombinant human erythropoietin in mildly anemic women before total hysterectomy.","volume":"30","author":"Dousias","year":"2003","journal-title":"Clin Exp Obstet Gynecol"},{"key":"R17-20230721","first-page":"129","article-title":"Administration of recombinant human erythropoietin in patients with gynecological cancer before radical surgery.","volume":"32","author":"Dousias","year":"2005","journal-title":"Clin Exp Obstet Gynecol"},{"key":"R18-20230721","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2106\/00004623-199601000-00009","article-title":"The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group.","volume":"78","author":"Faris","year":"1996","journal-title":"J Bone Joint Surg Am"},{"key":"R19-20230721","doi-asserted-by":"crossref","first-page":"845","DOI":"10.7326\/0003-4819-133-11-200012050-00008","article-title":"Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial.","volume":"133","author":"Feagan","year":"2000","journal-title":"Ann Intern Med"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000094811","article-title":"The use of erythropoietin in patients undergoing radical prostatectomy: effects on hematocrit, transfusion rates and quality of life.","volume":"77","author":"Gaston","year":"2006","journal-title":"Urol Int"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/STROKEAHA.109.549436","article-title":"The erythropoietin neuroprotective effect: assessment in CABG surgery (TENPEAKS): a randomized, double-blind, placebo controlled, proof-of-concept clinical trial.","volume":"40","author":"Haljan","year":"2009","journal-title":"Stroke"},{"key":"R22-20230721","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0039-6060(96)80261-3","article-title":"Perisurgical erythropoietin application in anemic patients with colorectal cancer: a double-blind randomized study.","volume":"119","author":"Heiss","year":"1996","journal-title":"Surgery"},{"key":"R23-20230721","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jcrc.2009.04.008","article-title":"Epoetin alfa reduces blood transfusion requirements in patients with intertrochanteric fracture.","volume":"25","author":"Kateros","year":"2010","journal-title":"J Crit Care"},{"key":"R24-20230721","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2168.1998.00564.x","article-title":"Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma.","volume":"85","author":"Kettelhack","year":"1998","journal-title":"Br J Surg"},{"key":"R25-20230721","doi-asserted-by":"crossref","first-page":"R254","DOI":"10.1186\/cc13081","article-title":"Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety.","volume":"17","author":"Kim","year":"2013","journal-title":"Crit Care"},{"key":"R26-20230721","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.athoracsur.2015.08.007","article-title":"Effect of a single bolus of erythropoietin on renoprotection in patients undergoing thoracic aortic surgery with moderate hypothermic circulatory arrest.","volume":"101","author":"Kim","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.SLA.0000055275.38740.56","article-title":"Perioperative erythropoietin administration in patients with gastrointestinal tract cancer: prospective randomized double-blind study.","volume":"237","author":"Kosmadakis","year":"2003","journal-title":"Ann Surg"},{"key":"R28-20230721","first-page":"51","article-title":"Effectiveness of perioperative epoetin alfa in patients scheduled for elective hip surgery.","volume":"33","author":"Laupacis","year":"1996","journal-title":"Semin Hematol"},{"key":"R29-20230721","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.amjsurg.2011.08.006","article-title":"A randomized, double-blind, placebo-controlled study to assess the effect of recombinant human erythropoietin on functional outcomes in anemic, critically ill, trauma subjects: the long term trauma outcomes study.","volume":"203","author":"Luchette","year":"2012","journal-title":"Am J Surg"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1537-2995.2010.02783.x","article-title":"Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty.","volume":"51","author":"Na","year":"2011","journal-title":"Transfusion"},{"key":"R31-20230721","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000106071","article-title":"Effect of darbepoetin alfa on physical function in patients undergoing surgery for colorectal cancer. A randomized, double-blind, placebo-controlled study.","volume":"71","author":"Norager","year":"2006","journal-title":"Oncology"},{"key":"R32-20230721","first-page":"341","article-title":"Elective coronary and valve surgery without blood transfusion in patients treated with recombinant human erythropoietin (epoetin-alpha).","volume":"48","author":"Podest\u00e0","year":"2000","journal-title":"Minerva Cardioangiol"},{"key":"R33-20230721","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s002689900561","article-title":"Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: reduced need for blood transfusions in patients undergoing colorectal surgery\u2013prospective double-blind placebo-controlled study.","volume":"23","author":"Qvist","year":"1999","journal-title":"World J Surg"},{"key":"R34-20230721","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/00005537-200207000-00015","article-title":"The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.","volume":"112","author":"Scott","year":"2002","journal-title":"Laryngoscope"},{"key":"R35-20230721","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-2143(97)90186-4","article-title":"The effect of preoperative recombinant human erythropoietin therapy on platelets and hemostasis in patients undergoing cardiac surgery.","volume":"129","author":"Sowade","year":"1997","journal-title":"J Lab Clin Med"},{"key":"R36-20230721","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood.V89.2.411","article-title":"Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery.","volume":"89","author":"Sowade","year":"1997","journal-title":"Blood"},{"key":"R37-20230721","first-page":"29","article-title":"Effect of recombinant human erythropoietin on anaemia after gastrectomy: a pilot study.","volume":"161","author":"Tsuji","year":"1995","journal-title":"Eur J Surg"},{"key":"R38-20230721","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1017\/S0265021505000426","article-title":"Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST).","volume":"22","author":"Weber","year":"2005","journal-title":"Eur J Anaesthesiol"},{"key":"R39-20230721","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jtcvs.2009.10.012","article-title":"Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study.","volume":"139","author":"Weltert","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R40-20230721","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/trf.13027","article-title":"A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial.","volume":"55","author":"Weltert","year":"2015","journal-title":"Transfusion"},{"key":"R41-20230721","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000049723","article-title":"Subcutaneous low-dose epoetin beta for the avoidance of transfusion in patients scheduled for elective surgery not eligible for autologous blood donation.","volume":"33","author":"Wurnig","year":"2001","journal-title":"Eur Surg Res"},{"key":"R42-20230721","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/ALN.0b013e318232004b","article-title":"Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery.","volume":"115","author":"Yoo","year":"2011","journal-title":"Anesthesiology"},{"key":"R43-20230721","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.288.22.2827","article-title":"Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.","volume":"288","author":"Corwin","year":"2002","journal-title":"JAMA"},{"key":"R45-20230721","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1711818","article-title":"Restrictive or liberal red-cell transfusion for cardiac surgery.","volume":"377","author":"Mazer","year":"2017","journal-title":"N Engl J Med"},{"key":"R46-20230721","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/trf.12903","article-title":"Trends in blood utilization in United States cardiac surgical patients.","volume":"55","author":"Robich","year":"2015","journal-title":"Transfusion"},{"key":"R47-20230721","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.clnu.2012.08.013","article-title":"Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS\u00ae) Society recommendations.","volume":"31","author":"Gustafsson","year":"2012","journal-title":"Clin Nutr"},{"key":"R48-20230721","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archsurg.2009.170","article-title":"Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations.","volume":"144","author":"Lassen","year":"2009","journal-title":"Arch Surg"},{"key":"R49-20230721","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1001\/jamasurg.2014.1841","article-title":"Surgical duration and risk of venous thromboembolism.","volume":"150","author":"Kim","year":"2015","journal-title":"JAMA Surg"},{"key":"R50-20230721","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V128.22.1177.1177","article-title":"Trends of inpatient venous thromboembolism rates in United States before and after surgeon general\u2019s call to action.","volume":"128","author":"Mehta","year":"2016","journal-title":"Blood"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201905000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:21:04Z","timestamp":1786112464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201905000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000004005","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}